Downregulation of HNRNPA1 inhibited tumor growth and increased CD8<sup>+</sup> T cell infiltration in vivo.<h4>Conclusion</h4>Our study demonstrated that targeting HNRNPA1 could produce immunogenic neoantigens that elicit anti-tumor immunity by inducing abnormal mRNA splicing. Here, CD8A is linked to neoplasm.